Group 1 - The core point of the article is that Dongyao Pharmaceutical-B (01875.HK) has appointed Zhongyi Capital Limited as an independent financial advisor to provide opinions to the independent board committee regarding a specific offer, particularly on whether the offer is fair and reasonable and whether it should be accepted [1] Group 2 - The appointment of the independent financial advisor has been approved by the independent board committee in accordance with Rule 2.1 of the Takeovers Code [1]